Three things to know:
1. Planning to commercialize the Pure-Vu System and its disposable sleeves, Motus is exploring partnerships with established medical device companies and commercial distributors in the European Union.
2. An estimated 1.2 million inpatient colonoscopies are performed in the EU each year, Motus GI CEO Tim Moran said in a press release.
3. Motus GI’s GEN2 Pure-Vu System is intended to minimize delayed and incomplete colonoscopies, improve exam quality and increase the number of adequately cleansed patients.
More articles on gastroenterology:
Exact Sciences lowers quarterly, full-year outlook due to COVID-19
Baseline colonoscopy results predict 10-year outcomes
CRH Medical’s board chairman resigns — 3 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.